Abstract

Clinically isolated syndrome (CIS) is the earliest clinical episode in multiple sclerosis (MS). Low environmental exposure to UV radiation is implicated in risk of developing MS, and therefore, narrowband UVB phototherapy might delay progression to MS in people with CIS. Twenty individuals with CIS were recruited, and half were randomised to receive 24 sessions of narrowband UVB phototherapy over a period of 8 weeks. Here, the effects of narrowband UVB phototherapy on the frequencies of circulating immune cells and immunoglobulin levels after phototherapy are reported. Peripheral blood samples for all participants were collected at baseline, and 1, 2, 3, 6 and 12 months after enrolment. An extensive panel of leukocyte populations, including subsets of T cells, B cells, monocytes, dendritic cells, and natural killer cells were examined in phototherapy-treated and control participants, and immunoglobulin levels measured in serum. There were significant short-term increases in the frequency of naïve B cells, intermediate monocytes, and fraction III FoxP3+ T regulatory cells, and decreases in switched memory B cells and classical monocytes in phototherapy-treated individuals. Since B cells are increasingly targeted by MS therapies, the effects of narrowband UVB phototherapy in people with MS should be investigated further.

Details

Title
Short-term changes in frequencies of circulating leukocytes associated with narrowband UVB phototherapy in people with clinically isolated syndrome
Author
Trend, Stephanie 1   VIAFID ORCID Logo  ; Jones, Anderson P 1 ; Cha Lilian 1 ; Cooper, Matthew N 1 ; Geldenhuys Sian 1 ; Fabis-Pedrini, Marzena J 2 ; Carroll, William M 2 ; Cole, Judith M 3 ; Booth, David R 4 ; Lucas, Robyn M 5   VIAFID ORCID Logo  ; French, Martyn A 6 ; Byrne, Scott N 7   VIAFID ORCID Logo  ; Kermode, Allan G 8 ; Hart, Prue H 1 

 University of Western Australia, Telethon Kids Institute, Perth, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910) 
 Perron Institute for Neurological and Translational Science, University of Western Australia, Sir Charles Gairdner Hospital, Centre for Neuromuscular and Neurological Disorders, Perth, Australia (GRID:grid.1012.2) 
 St John of God Hospital, St John of God Dermatology Clinic, Perth, Australia (GRID:grid.460013.0) 
 Westmead Institute for Medical Research, University of Sydney, Faculty of Medicine and Health, Westmead, Australia (GRID:grid.460013.0) 
 Australian National University, National Centre for Epidemiology & Population Health, Research School of Population Health, Canberra, Australia (GRID:grid.1001.0) (ISNI:0000 0001 2180 7477); University of Western Australia, Centre for Ophthalmology and Visual Science, Perth, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910) 
 University of Western Australia, UWA Medical School and School of Biomedical Sciences, Perth, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910) 
 Westmead Institute for Medical Research, University of Sydney, Faculty of Medicine and Health, Westmead, Australia (GRID:grid.1012.2) 
 Perron Institute for Neurological and Translational Science, University of Western Australia, Sir Charles Gairdner Hospital, Centre for Neuromuscular and Neurological Disorders, Perth, Australia (GRID:grid.1012.2); Institute for Immunology and Infectious Disease, Murdoch University, Perth, Australia (GRID:grid.1025.6) (ISNI:0000 0004 0436 6763) 
Publication year
2019
Publication date
2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2231412808
Copyright
© The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.